Damien Petty

Partner at Morpheus Ventures - Investing in Disruptive Tech and Helping Portfolio Companies Grow

📍 Santa Monica, California, United States🔄 Updated September 2026💼 14 investments📅 15 years investing🗓 Last invested Dec 2025
VC🌍 United StatesInvested this year
14
Total investments
5
Early stage
3
Mid stage
4
Late stage
15y
Years active

Portfolio

12 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Obsever / Investor
Dec 2025
Building the quantum networking technology to scale quantum computers. Stay Entangled!
Board Member / Investor
Sep 2023
Quoherents mission is to deploy the world’s first high-fidelity, scalable quantum processors on mobile platforms.
Observer / Investor
Jun 2023
Make quantum technology useful. We are the first to achieve quantum advantage through AI-powered infrastructure software.
Board Member / Investor
Jan 2022
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market. VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.
Board Member / Investor
Jan 2021
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance. At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply directly via LinkedIn or our website. We do not post job openings at other sites. Job seekers at Ten63 please check our website for additional information. https://www.ten63tx.com/job-seekers-announcement
Board Observer / Investor
Feb 2020
Rigetti is a pioneer in full-stack quantum computing. Rigetti quantum computers are based on superconducting qubits, which are widely believed to be the leading qubit modality given their maturity, clear path to scaling, and fast gate speeds. Current Rigetti quantum computing systems achieve gate speeds of 50-70ns, which is about 1,000 times faster than other modalities such as ion traps and neutral atoms. Rigetti sells on-premises 9-qubit to 108-qubit quantum computing systems, supporting national laboratories and quantum computing centers. Rigetti’s Cepheus 36-qubit to 108-qubit systems are based on the Company’s proprietary chiplet-based technology and include the Company’s control electronics. Rigetti’s 9-qubit Novera QPU supports a broader R&D community with a high-performance, on-premises QPU designed to plug into a customer’s existing cryogenic and control systems. The Company operates quantum computers over the cloud through its Rigetti Quantum Cloud Services (QCS) platform, enabling global enterprise, government, and research clients to pursue R&D. The Company’s proprietary quantum-classical infrastructure provides high-performance integration with public and private clouds for practical quantum computing. Rigetti developed the industry’s first multi-chip quantum processor for scalable quantum computing systems. Leveraging this proprietary technology, Rigetti deployed the industry’s largest multi-chip quantum computer in 2025 with Cepheus-1-36Q, based on four 9-qubit chiplets tiled together. The Company designs and manufactures its chips in-house at Fab-1, the industry’s first dedicated and integrated quantum device manufacturing facility.
Board Observer / Investor
Aug 2015
Starship Technologies is the world leader in autonomous robot delivery. Our robots have made more than 6 million deliveries globally - theyve travelled over 13 million kilometres and make 150,000 crossings each day. Sustainable, scalable, ethical and efficient - were revolutionising last-mile delivery. We partner with household names to deliver hot food, groceries and supplies in settings as diverse as US college campuses, local communities across Europe and on industrial sites.
Investor
Apr 2014
The Vicarious business has been acquired by Intrinsic, a robotics software and AI company at Alphabet. Together, we share an exciting mission to unlock the economic and creative potential of industrial robotics for millions of businesses, entrepreneurs and developers. Learn more about the work we will do together at www.intrinsic.ai. — Before joining Intrinsic, Vicarious built a thriving business as a turnkey robotics solutions integrator using AI to automate tasks too complex for traditional automation, by leveraging their deep expertise in neuroscience. Vicarious was founded in 2010 by Scott Phoenix and Dileep George, and backed by over $200M from investors like Jeff Bezos, Elon Musk, Mark Zuckerberg, and Samsung. Its technology has been published in peer-reviewed journals like Science and Science Robotics and featured by the New York Times, Wall Street Journal, MIT, Wired, and more.
Board Observer / Investor
Apr 2013
Forbes - 2019 Most Promising AI Companies Bossa Nova worked with the world’s largest retailers to create the leading AI-based image capture and analysis engine based on the market’s broadest library of images of grocery, general merchandise, and consumable products. Embedding Bossa Nova into your mobile app allows you to give your retail and CPG clients super powers: that is, x-ray vision into the real-time status of their products, promotions, planograms, shelves, stockrooms, and inventory. How do we do this? Bossa Nova identifies and locates every product, display and promotion in a store, and captures metadata that ties these products across stores and regions. For example, clients can compare category mixes across stores, correlate to sales, and infer optimal category placements. MORE COVERAGE Bossa Nova interprets images based upon the broadest labelled product library in the industry. This means that you can quickly increase your services to cover more brands, categories, and products. DELIVER SUPERIOR INSIGHT Retailers and CPGs have many questions about the shopper experience that just cannot be answered by the technologies and data available to them today. Point-of-sale, inventory data, and photos can only tell you what happened yesterday, not provide insight into what shoppers are seeing right now. Bossa Nova interprets images taken in the field in real-time and delivers detailed data and analytics for promotional displays, merchandising, product location, pricing, and stock outs—just to name a few.
Board Member
Oct 2012
CAIRE Diagnostics, formerly Spirosure Inc., based in Pleasanton, California, focuses on improving quality of life and asthma outcomes by bringing FeNO to everyone. CAIRE Diagnostics is a division of CAIRE Inc.
early stageMedical Device
Board Observer / Investor
Mar 2011
Vivino empowers people to enjoy wine to the fullest. Wine is about so much more than just a great label; it’s about an experience, community, and, of course, what’s in the bottle. That’s where Vivino comes in. As the world’s largest online wine marketplace and most downloaded wine app, our community comprises millions of wine drinkers worldwide, coming together to make buying the right wine simple, straightforward, and fun. We use crowd-sourced data to personalize wine recommendations so that every community member feels confident about their wine choices. Created for everyone who likes wine—from the wine curious to the wine enthusiast—the Vivino app is free on iOS and Android devices.
Board Observer
Mar 2011
Vivino empowers people to enjoy wine to the fullest. Wine is about so much more than just a great label; it’s about an experience, community, and, of course, what’s in the bottle. That’s where Vivino comes in. As the world’s largest online wine marketplace and most downloaded wine app, our community comprises millions of wine drinkers worldwide, coming together to make buying the right wine simple, straightforward, and fun. We use crowd-sourced data to personalize wine recommendations so that every community member feels confident about their wine choices. Created for everyone who likes wine—from the wine curious to the wine enthusiast—the Vivino app is free on iOS and Android devices.
Experience · 16 entries
All (16)
Investments (14)
Board (11)
2025
Board Obsever / Investor
Dec 2025
Building the quantum networking technology to scale quantum computers. Stay Entangled!
2023
Board Member / Investor
Sep 2023
Quoherents mission is to deploy the world’s first high-fidelity, scalable quantum processors on mobile platforms.
Observer / Investor
Jun 2023
Make quantum technology useful. We are the first to achieve quantum advantage through AI-powered infrastructure software.
2022
Board Member / Investor
Jan 2022
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market. VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.
2021
Board Member / Investor
Jan 2021
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance. At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply directly via LinkedIn or our website. We do not post job openings at other sites. Job seekers at Ten63 please check our website for additional information. https://www.ten63tx.com/job-seekers-announcement
Show all 16 entries ↓
Investment activity
2011–2025 · 14 investments
20112201232013120141201512020120211202212023220251
Recent (last 2 years)Earlier